Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09159138.8Aexternal-prioritypatent/EP2311825B1/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CY1117079T1publicationCriticalpatent/CY1117079T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Παράγωγα πυριμιδίνης, τα οποία είναι χρήσιμα ως αναστολείς του VEGFR2 περιγράφονται εις το παρόν. Η περιγραφείσα εφεύρεση συμπεριλαμβάνει επίσης και μεθόδους δημιουργίας τέτοιων παραγώγων πυριμιδίνης ως επίσης και μεθόδους χρήσεις των ιδίων στην αγωγή των υπερ-υπερπλαστικών παθήσεων.Pyrimidine derivatives useful as VEGFR2 inhibitors are described herein. The described invention also encompasses methods for generating such pyrimidine derivatives as well as methods for their own use in the treatment of hyperplastic diseases.
CY20151101170T2000-12-212015-12-22
Pyrimidines as modifiers of angiogenesis
CY1117079T1
(en)